Andrea Bergman is a federal health policy strategist who has successfully advocated for the full spectrum of healthcare stakeholders, including providers, payers, innovators, and patients. Andrea has a particular expertise in the policy and regulations that impact private health insurance, pharmacy benefits, and pharmaceutical regulation and reimbursement.
Andrea began her career on Capitol Hill as a health policy advisor to Senator Michael Crapo (R-ID), a senior Member of the Senate Finance and Senate Judiciary Committees. The Finance Committee has leading authority to set tax, trade, and health policy and has broad jurisdiction over health programs under the Social Security Act, most notably Medicare and Medicaid. The Senate Judiciary Committee has jurisdiction over patent and intellectual property rights for pharmaceuticals. Andrea served as the chief health advisor for the Senator in his work on important legislation ranging from the Health Insurance Portability & Accountability Act, the Bipartisan Patient Protection Act, and the Medicare, Medicaid and SCHIP Benefits Improvement and Protection Act.
Andrea is well regarded for her policy depth on healthcare reimbursement issues
and her ability to clearly communicate with decisionmakers about the impact of
of policy changes on diverse stakeholders. She developed this skill as a representative of the BlueCross BlueShield Association, PhRMA, and Medco where she advocated for policies that would promote innovation, protect patient access to care, enhance business growth opportunities, and deliver high-quality and cost effective care to patients. As a result of her work on federal health insurance reform and access to affordable prescription drugs, Andrea was appointed to a working group to examine existing prescription drug benefits in major Medicare reform proposals with the goal of developing a proposal for voluntary enrollment in a newly created Medicare Part D. Andrea was recognized by President George W. Bush for her contributions towards the development and passage of the Medicare Prescription Drug and Modernization Act (MMA) of 2003. Prior to joining the Stanton Park Group, Andrea served as Vice President of Federal Government Relations at McDermott, Will & Emery, LLC where she developed and coordinated strategies for influencing the federal legislative and regulatory processes.
Andrea is a graduate of California Polytechnic State University with a B.A. in Liberal Studies and a minor in Political Science and International Relations.